Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DYRK1A regulates Hap1–Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome

30 Jan 2017

Abstract excerpt

Huntingtin-associated protein 1 (Hap1) is known to be critical for postnatal hypothalamic function and growth. Hap1 forms stigmoid bodies (SBs), unique neuronal cytoplasmic inclusions of unknown function that are enriched in hypothalamic neurons. Here we developed a simple strategy to isolate the SB-enriched fraction from mouse brain. By analyzing Hap1 immunoprecipitants from this fraction, we identified a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down syndrome and intellectual disability research
Share to Genetics and Neurodevelopmental Disorders
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28137862
DOI: 10.1073/pnas.1614893114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DYRK1A regulates Hap1–Dcaf7/WDR68 binding with implication for delayed growth in Down syndromePMID 28137862Read ↗

Loss of Ahi1 affects early development by impairing BM88/Cend1-mediated neuronal differentiation.Semantic proximity Read ↗

New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down SyndromeSemantic proximity Read ↗

Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.Semantic proximity Read ↗

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down SyndromeSemantic proximity Read ↗

A CK2α–G3BP1 signaling axis regulates local translation in developing neurons and is disrupted in OCNDSSemantic proximity Read ↗

Prenatal treatment with rapamycin restores enhanced hippocampal mGluR-LTD and mushroom spine size in a Down’s syndrome mouse modelSemantic proximity Read ↗

DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and NeurogenesisSemantic proximity Read ↗

DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancersSemantic proximity Read ↗

Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1Semantic proximity Read ↗

Prenatal treatment with rapamycin restores enhanced hippocampal mGluR-LTD and mushroom spine size in a Down’s syndrome mouse modelSemantic proximity Read ↗

Phosphoproteomics identifies the DYRK1B protein kinase as a regulator of processing bodiesSemantic proximity Read ↗

The role of DYRK1A in neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.